An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab
2006 ◽
Vol 65
(4)
◽
pp. 538-541
◽
Keyword(s):